Early research (Phase 1)Ended earlyNCT01602627
What this trial is testing
Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies
Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Dale Shepard, MD, PhD 2